Neurosense Therapeutics Stock Forecast - Accumulation Distribution
| NRSN Stock | USD 1.12 0.10 9.80% |
Neurosense Stock Forecast is based on your current time horizon. Although Neurosense Therapeutics' naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Neurosense Therapeutics' systematic risk associated with finding meaningful patterns of Neurosense Therapeutics fundamentals over time.
Neurosense |
Most investors in Neurosense Therapeutics cannot accurately predict what will happen the next trading day because, historically, stock markets tend to be unpredictable and even illogical. Modeling turbulent structures requires applying different statistical methods, techniques, and algorithms to find hidden data structures or patterns within the Neurosense Therapeutics' time series price data and predict how it will affect future prices. One of these methodologies is forecasting, which interprets Neurosense Therapeutics' price structures and extracts relationships that further increase the generated results' accuracy.
The accumulation distribution (A/D) indicator shows the degree to which Neurosense Therapeutics is accumulated by the market over a given period. It uses the quote sensitivity to the highest or lowest daily price of Neurosense Therapeutics to determine if accumulation or reduction is taking place in the market. This value is adjusted by Neurosense Therapeutics trading volume to give more weight to distributions with higher volume over lower volume.| Previous Accumulation Distribution | Accumulation Distribution | Trend |
| 80512.42 | 0.16 |
| Check Neurosense Therapeutics Volatility | Backtest Neurosense Therapeutics | Information Ratio |
Neurosense Therapeutics Trading Date Momentum
| On June 29 2024 Neurosense Therapeutics was traded for 1.12 at the closing time. The top price for the day was 1.14 and the lowest listed price was 0.96 . There was no trading activity during the period 0.0. Lack of trading volume on June 29, 2024 did not cause price change. The trading delta at closing time against the current closing price is 8.93% . |
Accumulation distribution indicator can signal that a trend is either nearing completion, at a continuation, or is about to break-outs. The actual value of this indicator is of no significance. What is significant is the change in value of over time. The formula for A/D of a given trading day can be expressed as follow: ((Close - Low) - (High - Close)) / (High - Low) X Volume
| Compare Neurosense Therapeutics to competition |
Other Forecasting Options for Neurosense Therapeutics
For every potential investor in Neurosense, whether a beginner or expert, Neurosense Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Neurosense Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Neurosense. Basic forecasting techniques help filter out the noise by identifying Neurosense Therapeutics' price trends.Neurosense Therapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Neurosense Therapeutics stock to make a market-neutral strategy. Peer analysis of Neurosense Therapeutics could also be used in its relative valuation, which is a method of valuing Neurosense Therapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Neurosense Therapeutics Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Neurosense Therapeutics' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Neurosense Therapeutics' current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Neurosense Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how Neurosense Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Neurosense Therapeutics shares will generate the highest return on investment. By undertsting and applying Neurosense Therapeutics stock market strength indicators, traders can identify Neurosense Therapeutics entry and exit signals to maximize returns.
Neurosense Therapeutics Risk Indicators
The analysis of Neurosense Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Neurosense Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting neurosense stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 3.7 | |||
| Standard Deviation | 5.21 | |||
| Variance | 27.17 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectAdditional Information and Resources on Investing in Neurosense Stock
When determining whether Neurosense Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Neurosense Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Neurosense Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Neurosense Therapeutics Stock:Check out Historical Fundamental Analysis of Neurosense Therapeutics to cross-verify your projections. To learn how to invest in Neurosense Stock, please use our How to Invest in Neurosense Therapeutics guide.You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Neurosense Therapeutics. If investors know Neurosense will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Neurosense Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.93) | Return On Assets (2.22) | Return On Equity (4.95) |
The market value of Neurosense Therapeutics is measured differently than its book value, which is the value of Neurosense that is recorded on the company's balance sheet. Investors also form their own opinion of Neurosense Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Neurosense Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Neurosense Therapeutics' market value can be influenced by many factors that don't directly affect Neurosense Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Neurosense Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Neurosense Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Neurosense Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.